GILD ▲ +0.2% - Gilead Sciences, Inc.
$GILD New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/TDF in HIV Prevention
06-NOV-2026 12:16 PM ET
Share this post
More filings for $GILD
GILD ▲ +0.9% - Gilead Sciences, Inc.Nov 5, 2026GILD ▲ +4.5% - Gilead Sciences, Inc.Oct 30, 2026GILD ▲ +7.0% - Gilead Sciences, Inc.Oct 29, 2026GILD ▲ +2.4% - Gilead Sciences, Inc.Oct 22, 2026GILD ▲ +0.8% - Gilead Sciences, Inc.Oct 22, 2026GILD ▲ +0.4% - Gilead Sciences, Inc.Oct 19, 2026
View full $GILD filing history →💬 Comments
Loading comments…
Leave a comment